Brazilian Journal of Anesthesiology
https://bjan-sba.org/article/doi/10.1590/S0034-70942002000500013
Brazilian Journal of Anesthesiology
Review Article

Síndrome dolorosa complexa regional: epidemiologia, fisiopatologia, manifestações clínicas, testes diagnósticos e propostas terapêuticas

Complex regional pain syndrome: epidemiology, pathophysiology, clinical manifestations, diagnostic tests and therapeutic proposals

Francisco Carlos Obata Cordon; Lino Lemonica

http://dx.doi.org/10.1590/S0034-70942002000500013 Braz J Anesthesiol, vol.52, n5, p.618-627, 2002
PDF
Downloads: 0
Views: 1125

Resumo

JUSTIFICATIVA E OBJETIVOS: A Síndrome Dolorosa Complexa Regional (SDCR), assim denominada a partir de 1994 pelo Consenso da Associação Internacional para o Estudo da Dor (AIED) e anteriormente denominada de várias formas, tais como Distrofia Simpático Reflexa, Causalgia, Algodistrofia ou Atrofia de Sudeck, é uma doença cuja compreensão dos limites clínicos, fisiopatologia e implicações de patogenia ainda é pobre. Disto resulta a enorme insatisfação não só para os pacientes como para os profissionais da saúde quanto aos métodos terapêuticos atualmente disponíveis. O objetivo deste trabalho é rever a literatura e atualizar um conjunto de informações com o intuito da melhor compreensão desta importante síndrome dolorosa. CONTEÚDO: Este é um trabalho de revisão da literatura nos diversos aspectos da SDCR, com ênfase em suas causas, definição e taxonomia, fisiopatologia, características clínicas, testes diagnósticos e propostas de tratamentos mais recentes. CONCLUSÕES: Poucos são os estudos controlados adequadamente, encobertos e aleatórios, publicados com grandes amostras, havendo muitas dúvidas sobre esta doença. Desta forma, ainda há enorme empirismo na sua terapêutica, e os resultados obtidos são insatisfatórios.

Palavras-chave

DOR, DOR

Abstract

BACKGROUND AND OBJECTIVES: The term Complex Regional Pain Syndrome (CRPS) was adopted as from 1994 by the International Association for Study of Pain (IASP) Consensus. It previously referred to by several other names, such as Reflex Sympathetic Dystrophy, Causalgia, Algodystrophy or Sudeck’s Atrophy, and is a disease where the understanding of clinical limits, pathophysiology and pathogenic implications is still very poor. Thus resulting in disappointment both for patients and for health professionals with regard to currently available therapies. This study aimed at reviewing the literature and updating information to improve the understanding of this severe painful syndrome. CONTENTS: This study is a literature review of several CRPS aspects, with emphasis in its causes, definition and taxonomy, pathophysiology, clinical characteristics, diagnostic tests and most recent therapies. CONCLUSIONS: There are few well controlled, double blind and randomized CRPS studies with large samples, and there are still several questions about this disease. The treatment is usually empirical and the patient outcome is poor.

Keywords

PAIN, PAIN

Referencias

Mitchell SW. On the Diseases of Nerves, Resulting from Injuries. Contribution Relating to the Causation and Prevention of Disease, and to Camp Disease. 1867.

Paget J. Clinical lecture on some cases of local paralysis. Med Times. 1864:331-332.

Wolff J. Ueber einen Fall von Ellenbogensgelenks-Reaktion. Arch Chir. 1877;20:771.

Bonica JJ. The Management of Pain. 1953.

Merskey H, Bogduk N. Classification of Chronic Pain. 1994.

Hiraden R N, Bruehl S. Complex regional pain syndrome: are the IASP diagnostic criteria valid and sufficient comprehensive?. Pain. 1999;83:211-219.

Stanton-Hicks M, Janig W, Hassenbusch S. Reflex sympathetic dystrophy: changing concepts and taxonomy. Pain. 1995;63:127-133.

Ali Z, Raja SN, Wesselmann U. Intradermal injection of norepinephrine evokes pain in patients with sympathetically maintained pain. Pain. 2000;88:161-168.

Baron R. The influence of sympathetic nerve activity and catecholamines on primary afferent neurons. IASP Newsl. 1998:3-8.

Ro LS, Chen ST, Tang LM. Effects of NGF and anti-NGF on neuropathic pain in rats following chronic constriction injury of the sciatic nerve. Pain. 1999;79:265-274.

Owolabi JB, Rikalla G, Tehim A. Characterization of antiallodynic actions of ALE-0540, a novel nerve growth factor receptor antagonist, in the rat. J Pharmacol Exp Ther. 1999;289:1271-1276.

Mannion RJ, Costigan M, Decosterd I. Neurotrophins: peripherally and centrally acting modulators of tactile stimulus-induced inflammatory pain hypersensitivity. Proc Natl Acad Sci USA. 1999;96:9385-9390.

Giovengo SL, Russell IJ, Larson AA. Increased concentrations of nerve growth factor in cerebrospinal fluid of patients with fribromyalgia. J Rheumatol. 1999;26:1564-1569.

Nauta HJ, Wehman JC, Koliatsos VE. Intraventricular infusion of nerve growth factor as the cause of sympathetic fiber sprouting in sensory ganglia. J Neurosurg. 1999;91.

Drummond PD, Finc PM, Smythe GA. Reflex sympathetic dystrophy: the significance of differing plasma catecholamine concentrations in affected and unaffected limbs. Brain. 1991;114:2025-2036.

Harden RN, Duc TA, Willians TR. Norepinephrine and epinephrine levels in affected versus unaffected limbs in sympathetically maintained pain. Clin J Pain. 1994;10:324-330.

Wasner G, Heckmann K, Maier C. Vascular abnormalities in acute reflex sympathetic dystrophy (CRPS I): complete inhibition of sympathetic nerve activity with recovery. Arch Neurol. 1999;56:613-620.

Loh L, Nathan PW. Painful peripheral states and sympathetic blocks. J Neurosurg Psychiatry. 1978;41:664-671.

Veldman PH, Reynen HM, Artz IE. Signs and symptoms of reflex sympathetic dystrophy: prospective study of 829 patients. Lancet. 1993;342:1012-1016.

Allen G, Galer BS, Schwartz L. Epidemiological review of 134 patients with complex regional pain syndrome assessed in a chronic pain clinic. Pain. 1999;80:539-540.

Berstein BH, Singsen BH, Kent JT. Reflex neuromuscular dystrophy in childhood. J Pediatr. 1978;93:211-215.

Stanton RP, Malcolm JR, Wesdck KA. Reflex sympathetic dystrophy in children: an orthopedic perspective. Orthopedics. 1993;16:773-779.

Ashwal S, Tomasi L, Neumann M. Reflex sympathetic dystrophy in children. Pediatr Neurol. 1988;4:38-42.

Allen G, Galler BS, Veldman PJM. Multiple reflex sympathetic dystrophy: Which patients are at risk for developing a recurrence of reflex sympathetic dystrophy in the same or another limb. Pain. 1996;64:463-466.

Sherry DD, Weisman R. Psychological aspects of childhood reflex neuromuscular dystrophy. Pediatr. 1988;81:572-578.

Kemler MA, Vusse AC, Berg-Loonen EM. HLA-DQ1 associated with reflex sympathetic dystrophy. Neurology. 1999;53:1350-1351.

Monti DA, Herring CL, Schwartz RJ. Personality assessment of patients with complex regional pain syndrome Type I. Clin J Pain. 1998;14:295-302.

Haddox JD, Abran SE, Hopwood MH. Comparison of psychometric data in RSD and radiculopathy. Reg Anesth. 1988;13:27.

Sudeck P. Die sogennante knochenatrophine als entzundung- svorgang. Chirurg. 1942;15:449-457.

Levine JD, Fields HL, Basbaum AL. Peptides and the primary afferent nociceptor. J Neurosci. 1993;13:2273-2286.

Zollinger PE, Tuinebreijer WE, Kreis RW. Effects of vitamin C on frequency of reflex sympathetic dystrophy in wrist fractures: a randomized trial. Lancet. 1999;354:2025-2028.

Coderre TJ, Katz J, Accarino AL. Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidences. Pain. 1993;52:259-285.

Leriche R. La chirurgie de la doloure. 1939.

Payne R. Reflex Sympathetic Dystrophy Syndrome: Diagnosis and Treatment. Pain Syndromes in Neurology. 1990:107-129.

Gales BS, Jensen M. Development and preliminary validation of a pain measure specific to neuropathic pain: the neuropathic pain scale. Neurology. 1997;48:332-339.

Baron R, Maier C. Reflex Sympathetic dystrophy: skin blood flow, sympathetic vasoconstrictor reflex and pain before and after surgical sympathectomy. Pain. 1996;67:317-326.

Kemler MA, Schouten HJA, Gracely RH. Diagnosing sensory abnormalities with either normal values or values from contralateral skin: comparison of two approaches in complex regional pain syndromes. Anesthesiology. 2000;93:718-727.

Bruehl S, Carlson CR. Predisposing psychological factors in the development of reflex sympathetic dystrophy. Clin J Pain. 1992:287-299.

Geertzen JHB, deBrujin H, deBrujin-Kofman AT. - Reflex sympathetic dystrophy: early treatment and psychological aspects. Arch Phys Rehabil. 1994;75:442-446.

Bruehl S, Husfeldt B, Lubenow TR. Psychological differences between reflex sympathetic dystrophy and non-RSD chronic pain patients. Pain. 1996;67:107-114.

Kozin F, Soin JS, Ryan LM. Bone scintilography. I: The reflex sympathetic dystrophy syndrome. Radiology. 1981;138:437-443.

Bruehl S, Lubenow TR, Nath H. Validation of thermograph in the diagnosis of reflex sympathetic dystrophy. Clin J Pain. 1994;10:146-155.

Sandroni P. Testing the autonomic nervous system. IASP Newsl. 1998:3-6.

Wilson PR. Post-traumatic upper extremity reflex sympathetic dystrophy. Hand Clin. 1997;17:367-372.

Lopez RF. Reflex sympathetic dystrophy: timely diagnosis and treatment can prevent severe contractors. Postgrad Med. 1997;101:185-190.

Doury PCC. Algodystrophy: a spectrum of disease, historical perspectives, criteria of diagnosis, and principles of treatment. Hand Clin. 1997;13:327-337.

Cooney WP. Somatic versus sympathetic mediated chronic limb pain: experience and treatment options. Hand Clin. 1997;13:355-361.

Hardy MA, Hardy SG. Reflex sympathetic dystrophy: the clinician’s perspective. J Hand Ther. 1997;10:137-150.

Bonica JJ. Sympathetic nerve blocks for pain diagnosis and therapy. 1980;1:28-398.

Ramamurthy S, Hoffman JRN. Intravenous regional guanethidine in the treatment of reflex sympathetic dystrophy/causalgia: a randomized, double-blind study. Anesth Analg. 1995;81:718-723.

Valentin N. Reflex sympathetic dystrophy treated with guanethidine: Time for a change of name and strategy. Acta Anaesthesiol Scand. 1996;40:1171-1172.

Kaplan R, Claudio M, Kepes E. Intravenous guanethidine in patients with reflex sympathetic dystrophy. Acta Anaesthesiol Scand. 1996;40:1216-1222.

McKain CW, Urban BJ, Goldner JL. The effects of intravenous regional guanethidine and reserpine: a controlled study. J Bone Joint Surg Am. 1983;65:808-811.

Hord Ah, Rooks MD, Stephensen BO. Intravenous regional bretylium and lidocaine for treatment of reflex sympathetic dystrophy: a randomized, double-blind study. Anesth Analg. 1992;74:818-821.

Tountas AA, Noguchi A. Treatment of post-traumatic reflex sympathetic dystrophy (RSDS) with intravenous blocks of o mixture of corticosteroid and lidocaine: a retrospective review of 17 consecutive cases. J Orthop Trauma. 1991;4:412-419.

Furst CL. The biochemistry of guanethidine. Adv Drug Res. 1967;4:133-136.

Kingery WS. A critical review of controlled clinical trial for peripheral neuropathic pain and complex regional pain syndrome. Pain. 1997;73:123-139.

Rocco AG, Kaul AF. A comparison of regional intravenous guanethidine and reserpine in reflex sympathetic dystrophy: a controlled, randomized, double-blind, and crossover study. Clin J Pain. 1989;5:205-209.

Blanchard J, Ramamurthy S, Walsh N. Intravenous regional sympatholysis: a double-blind comparison of guanethidine, reserpine and normal saline. J Pain Symptom Manage. 1990;5:357-361.

Galer BS. Preliminary report: peak pain relief is delayed and duration of relief is extended following intravenous phentolamine infusion. Reg Anaesth. 1995;20:444-447.

Ramirez JM, French AS. Phentolamine selectively affects the fast sodium channel component of sensory adaptation in an insect mechanoreceptor. J Neurobiol. 1990:893-899.

Raja AN, Treede RD, Davis KD. Systemic alpha-adrenergic blockade with phentolamine: a diagnostic test for sympathetically maintained pain. Anesthesiology. 1991;74:691-698.

Raja SN, Turquist JL, Meleka SM. Monitoring adequacy of adrenergic blockade following systemic phentolamine administration. Pain. 1996;64:197-204.

Rauck RL, Eisenach JC, Jackson K. Epidural clonidine treatment for refractory reflex sympathetic dystrophy. Anesthesiology. 1993;79:1163-1169.

Kabeer AA, Hardy AJ. Long-term use of subarachnoid clonidine for analgesia in refractory reflex sympathetic dystrophy. Reg Anesth. 1996;21:249-252.

Reuben SS, Steiberg RB, Madabhushi L. Intravenous regional clonidine in management of sympathetically maintained pain. Anesthesiology. 2000;89:527-530.

Davis KD, Treede RD, Raja SN. Topical application of clonidine relieves hyperalgesia in patients with sympathetically maintained pain. Pain. 1991;47:309-317.

Devers A, Galer BS. Open-label trial of topical clonidine gel for the treatment of postherpetic neuralgia and complex regional pain syndrome. 1998.

Karlstem R, Gordh T. Adenosine: A new analgesic for the treatment of neuropathic pain?. . 2000;1:3-6.

Bickerstaff DR, Kanis JA. The use of nasal calcitonin in the treatment of post-traumatic algodystrophy. Br J Rheumatol. 1991;30:291-294.

Mao J, Chen L. Systemic lidocaine for neuropathic pain relief. Pain. 2000;97:7-17.

Koppert W, Ostermier N, Sittl R. Low-dose lidocaine reduces secondary hyperalgesia by a central mode of action. Pain. 2000;85:217-224.

Wallace MS, Ridgeway BM, Leung AY. Concentration-effect relationship of intravenous lidocaine on the allodynea of complex regional pain syndrome. Anesthesiology. 2000;92:75-89.

Wallace MS, Magnuson S, Ridgeway B. Efficacy of oral mexiletine for neuropathic pain with allodynia: a double-blind, placebo-controlled, crossover study. Reg Anesth Pain Med. 2000;25:459-467.

Backonja MM. Reflex sympathetic dystrophy/sympathetically maintained pain/causalgia: the syndrome of neurophatic pain with dysautonomia. Semin Neurol. 1994;14:263-271.

Azad S, Beyer A, Galler R. Continuous axillary brachial plexus analgesia with low dose morphine in patients with complex regional pain syndrome. Eur J Anesthesiology. 2000;17:185-188.

Melnick GA, Melnick LB. Gabapentin in management of reflex sympathetic dystrophy. J Pain Symptom Manage. 1994;10:265-266.

Kemler MA, Barense GAM, VanKleef M. Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. New Engl J Med. 2000;343:618-624.

Sweet JC, Pollet CE. Causalgia and Sympathetic Dystrophy (Sudeck’s atrophy): Evaluation and Treatment of Chronic Pain. 1985:149-165.

5dd582850e8825f32dc8fca6 rba Articles
Links & Downloads
2352-2291 (Electrónico) 0104-0014 (Impreso)
Braz J Anesthesiol ©2024 Todos los derechos reservados.

Braz J Anesthesiol

Share this page
Page Sections